Comparison of two antibiotic regimens in patients with positive VAP caused by Acinetobacter
Phase 4
Recruiting
- Conditions
- Acinetobacter infection.Pneumonia due to other specified bacteriaJ15.8
- Registration Number
- IRCT20221102056386N2
- Lead Sponsor
- Bandare-abbas University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Ventilator-Associated Pneumonia (VAP) confirmed by a doctor
age 18 or older
Hospitalization in the intensive care unit (ICU)
obtaining informed consent from the patient or the patient's companion
history of sensitivity to antibiotics in the laboratory
Exclusion Criteria
Organ transplant or bone marrow transplant
Being treated for human immunodeficiency virus (HIV)
Receiving another antibiotic from another hospital within less than 72 hours
Pregnancy
Having an incurable disease
Blood malignancy without a treatment plan
Resistance to therapeutic antibiotics
Having another infection along with Ventilator-associated pneumonia (VAP)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determining the effectiveness of the intervention. Timepoint: During the study period. Method of measurement: Examination of clinical symptoms during the intervention period.
- Secondary Outcome Measures
Name Time Method Comparison of hospitalization in ICU and hospital. Timepoint: Duration of the study. Method of measurement: check list.;The effect of treatment on the duration of the patient's recovery during the intervention period. Timepoint: Duration of the study. Method of measurement: Clinical symptoms and laboratory tests.;Mortality. Timepoint: end of the study. Method of measurement: check list.;Kidney function. Timepoint: duration of the study. Method of measurement: Measurement of creatinine and blood urea nitrogen levels.